IGEA Pharma N.V. – SIX:IGPH.SW
IGEA Pharma N.V. stock price today
IGEA Pharma N.V. stock price monthly change
IGEA Pharma N.V. stock price yearly change
IGEA Pharma N.V. key metrics
Market Cap | 505.54K |
Enterprise value | 1.22M |
P/E | -0.20 |
EV/Sales | 323.24 |
EV/EBITDA | -1.08 |
Price/Sales | 69.21 |
Price/Book | 0.02 |
PEG ratio | 0.02 |
EPS | -0.03 |
Revenue | N/A |
EBITDA | -5.98M |
Income | -12.15M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -33397.37% |
Oper. margin | -34368.42% |
Gross margin | -7734.21% |
EBIT margin | -34368.42% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeIGEA Pharma N.V. stock price history
IGEA Pharma N.V. stock forecast
IGEA Pharma N.V. financial statements
| Sep 2022 | -2.79K | -5.62M | 201383.78% |
|---|---|---|---|
| Dec 2022 | -3.05K | -6.14M | 201377.22% |
| Mar 2023 | 0 | -192.86K | |
| Jun 2023 | 0 | -194.02K |
| Payout ratio | 0% |
|---|
| 2018 | 0.1% |
|---|---|
| 2019 | |
| 2020 | |
| 2021 | |
| 2022 |
| Jun 2022 | 11354800 | 1.68M | 14.81% |
|---|---|---|---|
| Dec 2022 | 222000 | 2.62M | 1181.08% |
| Mar 2023 | 0 | 1.28M | Infinity% |
| Jun 2023 | 105200 | 1.18M | 1130.23% |
| Sep 2022 | -85.39K | -52.62K | 109.99K |
|---|---|---|---|
| Dec 2022 | -93.31K | -57.5K | 120.19K |
| Mar 2023 | -110.09K | 142.26K | -12.63K |
| Jun 2023 | -110.75K | 143.11K | -12.71K |
IGEA Pharma N.V. alternative data
| Aug 2023 | 1 |
|---|---|
| Sep 2023 | 1 |
| Oct 2023 | 1 |
| Nov 2023 | 1 |
| Dec 2023 | 1 |
| Jan 2024 | 1 |
| Feb 2024 | 1 |
| Mar 2024 | 1 |
| Apr 2024 | 1 |
| May 2024 | 1 |
| Jun 2024 | 1 |
| Jul 2024 | 1 |
IGEA Pharma N.V. other data
-
What's the price of IGEA Pharma N.V. stock today?
One share of IGEA Pharma N.V. stock can currently be purchased for approximately $0.19.
-
When is IGEA Pharma N.V.'s next earnings date?
Unfortunately, IGEA Pharma N.V.'s (IGPH.SW) next earnings date is currently unknown.
-
Does IGEA Pharma N.V. pay dividends?
No, IGEA Pharma N.V. does not pay dividends.
-
How much money does IGEA Pharma N.V. make?
IGEA Pharma N.V. has a market capitalization of 505.54K.
-
What is IGEA Pharma N.V.'s stock symbol?
IGEA Pharma N.V. is traded on the SIX under the ticker symbol "IGPH.SW".
-
What is IGEA Pharma N.V.'s primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of IGEA Pharma N.V.?
Shares of IGEA Pharma N.V. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does IGEA Pharma N.V. have?
As Jul 2024, IGEA Pharma N.V. employs 1 workers.
-
When IGEA Pharma N.V. went public?
IGEA Pharma N.V. is publicly traded company for more then 6 years since IPO on 20 Dec 2018.
-
What is IGEA Pharma N.V.'s official website?
The official website for IGEA Pharma N.V. is igeapharma.nl.
-
How can i contact IGEA Pharma N.V.?
IGEA Pharma N.V. can be reached via phone at +31 23 568 9494.
IGEA Pharma N.V. company profile:
IGEA Pharma N.V.
igeapharma.nlSIX
1
Medical - Diagnostics & Research
Healthcare
IGEA Pharma N.V. commercializes health-tech and med-tech products and devices in in the United States and the Netherlands. It offers Alz1, an at-home lab test kit to measure non-bound copper in the blood; dietary supplement products to reduce blood heavy metals content under the Alz1 Tab brand; and COVID19 rapid test for the detection of IgM and IgG SARS-CoV-2 related antibodies. The company also provides dry aerosol generators for air and inanimate environmental surfaces sanitization, as well as air sterilization and purification devices. In addition, it engages in laboratory analysis. The company was incorporated in 2015 and is headquartered in Hoofddorp, the Netherlands.
Hoofddorp, 2132 WT
:
ISIN: NL0012768675
CUSIP: N43975106
